Shandong Suncadia Medicine Co., Ltd.
Clinical trials sponsored by Shandong Suncadia Medicine Co., Ltd., explained in plain language.
-
New pill aims to tackle high blood pressure in overweight patients
Disease control Not yet recruitingThis study tests an experimental drug called HRS-7535 to see if it can lower blood pressure better than a placebo in adults aged 18-70 who have both high blood pressure and overweight or obesity. About 648 participants will take the drug or a dummy pill for up to 48 weeks. The ma…
Phase: PHASE3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:31 UTC
-
New hope for lung cancer patients who stopped responding to treatment
Disease control Not yet recruitingThis study tests a new drug called HRS-7058 in people with advanced or spreading non-small cell lung cancer that has a specific change in the KRAS gene (G12C). Participants must have already tried standard treatments without success. The study compares HRS-7058 to other KRAS G12C…
Phase: PHASE3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:26 UTC
-
New hope for hard-to-treat pancreatic cancer: targeted drug enters phase 2 trial
Disease control Not yet recruitingThis study tests an experimental drug called HRS-7058 in people with advanced pancreatic cancer that has a specific change in the KRAS gene (G12C mutation). Participants must have already tried at least one other cancer treatment. The goal is to see if the drug can shrink tumors …
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
Kidney Drug's journey through the body tracked in tiny study
Knowledge-focused Not yet recruitingThis study gives a single dose of a new kidney disease drug (HRS-1780) to 6 healthy men to see how it is absorbed, broken down, and eliminated. It does not treat the disease but helps researchers understand the drug's behavior and safety. Participants must be healthy males aged 1…
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 22, 2026 13:55 UTC
-
Scientists track breast cancer Drug's path in healthy volunteers
Knowledge-focused Not yet recruitingThis study will give a radioactive version of a breast cancer drug to 6 healthy postmenopausal women. The goal is to see how the drug moves through the body, how it breaks down, and how it leaves the body. This helps researchers understand the drug better before testing it in pat…
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 18, 2026 12:08 UTC